150 related articles for article (PubMed ID: 7301710)
21. Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype.
Molderings GJ; Werner K; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):371-7. PubMed ID: 2255330
[TBL] [Abstract][Full Text] [Related]
22. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
23. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.
Verbeuren TJ; Jordaens FH; Herman AG
J Pharmacol Exp Ther; 1983 Aug; 226(2):579-88. PubMed ID: 6875866
[TBL] [Abstract][Full Text] [Related]
24. Actions of co-dergocrine mesylate and its components at vascular smooth muscle.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):225-33. PubMed ID: 7063048
[TBL] [Abstract][Full Text] [Related]
25. Prejunctional beta-adrenoceptors in human and canine saphenous veins.
Verbeuren TJ; Lorenz RR; Aarhus LL; Shepherd JT; Vanhoutte PM
J Auton Nerv Syst; 1983 Jul; 8(3):261-71. PubMed ID: 6321585
[TBL] [Abstract][Full Text] [Related]
26. Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.
Engel G; Göthert M; Müller-Schweinitzer E; Schlicker E; Sistonen L; Stadler PA
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):116-24. PubMed ID: 6646239
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.
Janssen P; Prins NH; Meulemans AL; Lefebvre RA
Br J Pharmacol; 2002 May; 136(2):321-9. PubMed ID: 12010782
[TBL] [Abstract][Full Text] [Related]
28. Histamine and 5-hydroxytryptamine-inhibition of transmitter release mediated by H2- and 5-hydroxytryptamine receptors.
McGrath MA; Shepherd JT
Fed Proc; 1978 Feb; 37(2):195-8. PubMed ID: 23966
[TBL] [Abstract][Full Text] [Related]
29. Serotonergic modulation of murine fundic tone.
Xue L; Camilleri M; Locke GR; Schuurkes JA; Meulemans A; Coulie BJ; Szurszewski JH; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1180-6. PubMed ID: 16873894
[TBL] [Abstract][Full Text] [Related]
30. An examination of 5-hydroxytryptamine receptors in human saphenous vein.
Docherty JR; Hyland L
Br J Pharmacol; 1986 Sep; 89(1):77-81. PubMed ID: 3801780
[TBL] [Abstract][Full Text] [Related]
31. Characterization by cyproheptadine of the dopamine-induced contraction in canine isolated arteries.
Gilbert JC; Goldberg LI
J Pharmacol Exp Ther; 1975 May; 193(2):435-42. PubMed ID: 1142100
[TBL] [Abstract][Full Text] [Related]
32. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
de Ridder WJ; Schuurkes JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
[TBL] [Abstract][Full Text] [Related]
33. Effects of serotonin and endothelin on the smooth muscle cells of autogenous vein grafts.
Mawatari K; Komori K; Kuma S; Yamamura S; Ishii T; Sugimachi K
Br J Surg; 1997 Oct; 84(10):1419-24. PubMed ID: 9361603
[TBL] [Abstract][Full Text] [Related]
34. Amplification of 5-hydroxytryptamine-induced contractile responses via 5-hydroxytryptamine receptors and alpha-adrenoceptors in dog mesenteric artery and vein.
Shimamoto H; Shimamoto Y; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1994 Feb; 268(2):779-84. PubMed ID: 8113990
[TBL] [Abstract][Full Text] [Related]
35. The prejunctional and postjunctional effects of acetylcholine in the blood vessel wall.
Vanhoutte PM
Verh K Acad Geneeskd Belg; 1982; 44(5-6):269-94. PubMed ID: 6306945
[No Abstract] [Full Text] [Related]
36. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
Cushing DJ; Zgombick JM; Nelson DL; Cohen ML
J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins.
Glusa E; Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):133-6. PubMed ID: 8474533
[TBL] [Abstract][Full Text] [Related]
38. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S
Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498
[TBL] [Abstract][Full Text] [Related]
39. Differential inhibition by ergonovine of norepinephrine release in the coronary artery and saphenous vein of the dog.
O'Rourke ST; Vanhoutte PM
J Pharmacol Exp Ther; 1989 Apr; 249(1):52-5. PubMed ID: 2709336
[TBL] [Abstract][Full Text] [Related]
40. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.
Müller-Schweinitzer E; Engel G
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):287-92. PubMed ID: 6664382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
